Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
Yesenia L Franco,* Tanaya R Vaidya,* Sihem Ait-Oudhia Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA *These authors contributed equally to this work Abstract: Breast cancer (BC) is a highly prevalent dise...
Guardado en:
Autores principales: | Franco YL, Vaidya TR, Ait-Oudhia S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2b365b508034eafa2fb3a030de4fa18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio
por: Marjorie Coimbra Roque, et al.
Publicado: (2021) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
por: Singh S
Publicado: (2018) -
Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells
por: Tsang YW, et al.
Publicado: (2019) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016) -
Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancer
por: Yin Shi, et al.
Publicado: (2021)